Analysis

PowerShares Emerging Markets Sovereign Debt Portfolio (PCX:PCY)

The PowerShares Emerging Markets Sovereign Debt Portfolio ETF (PCY) invests in emerging market sovereign bonds with an attractive yield of 6.38%. Despite a slightly high volatility of 10.21%, this ETF offers protection against dollar fluctuations and monthly distributions, making it an attractive instrument to diversify your portfolio.

PowerShares Emerging Markets Sovereign Debt Portfolio (PCX:PCY) Read More »

Novartis (VTX:NOVN)

Discover the detailed analysis of Novartis, the pharmaceutical giant born from the merger of Ciba-Geigy and Sandoz, and its dividend policy that raises ethical and economic questions. Between job cuts and sustainable dividend growth, let's explore how this global leader in pharma balances its social responsibilities and financial performance.

Novartis (VTX:NOVN) Read More »

Astrazeneca (NYSE:AZN)

AstraZeneca, the pharmaceutical giant born from the merger of Astra AB and Zeneca PLC, has established itself as one of the world leaders in the sector with around 100,000 employees dedicated to the research, development and marketing of pharmaceutical products. The group presents solid financial indicators, with an attractive yield and a generous dividend distribution policy, although investors should be cautious due to the relative youth of its successive dividend increases.

Astrazeneca (NYSE:AZN) Read More »

Praxair (NYSE:PX)

Discover Praxair Inc (NYSE:PX), a leading North and South American supplier of industrial gases, distinguished by its global presence and impressive patent portfolio. Despite solid stock performance and stable dividend growth, its current valuation suggests a holding strategy for existing investors rather than a new buying opportunity.

Praxair (NYSE:PX) Read More »